← Leaderboards
Michael A Gelman
Stanford University
$532,764
Attributed
$532,764
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $133.2K · FY2012–15$200K$150K$100K$50K$0
'12
'13
'14
'15
Funding mix
By agency
NIH$532,764 · 1
By mechanism
K08$532,764 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Jeffrey S Glenn$57,102,148
- Mark A Kay$46,920,488
- Martha S Cyert$24,969,287
- Edward S. Mocarski$11,996,025
- Katherine S Bateman$23,085
Others in their field
Top investigators on “1-Phosphatidylinositol 4-Kinase”
- Lewis C Cantley · Beth Israel Deaconess Medical Center$13,318,180
- Jeffrey S Glenn · Stanford University$7,058,956
- Karin M Reinisch · Yale University$5,542,483
- Jonathan M Kurie · University Of Tx Md Anderson Can Ctr$4,581,221
- Brooke M Emerling · Sanford Burnham Prebys Medical Discovery Institute$4,446,740
- Sharona E Gordon · University Of Washington$2,821,191
Research focus
1-Phosphatidylinositol 4-KinaseAdverse EffectsAffectAnalogAnesthesia ProceduresAnimal ModelAnti-Hepatitis CAntiviral AgentsAntiviral ResistanceBasic Amino AcidsBinding (Molecular Function)BiologicalBiological ModelsBiomedical EngineeringCareerCell Culture TechniquesCell MembraneCellsCessation Of LifeChronic Hepatitis CCirrhosisCollaborationsCombined Modality Therapy1-Phosphatidylinositol 3-Kinase
Grant awards (4)
Antivirals for Hepatitis C Targeting Phosphoinositide Metabolism$133,191
K08 · FY2015 · AI · contact PI
Antivirals for Hepatitis C Targeting Phosphoinositide Metabolism$133,191
K08 · FY2014 · AI · contact PI
Antivirals for Hepatitis C Targeting Phosphoinositide Metabolism$133,191
K08 · FY2013 · AI · contact PI
Antivirals for Hepatitis C Targeting Phosphoinositide Metabolism$133,191
K08 · FY2012 · AI · contact PI